NEW BRIEF: Promoting Transparency and Competition in the Drug Market
 
Wayne Winegarden
October 10, 2022

The goal of pharmaceutical regulations should be to improve the quality of healthcare by simultaneously promoting innovation and fostering wider affordability. Achieving these goals requires reforms that eliminate the disincentives that pervade the current drug market.


Read more. . .

Hospitals are still hiding costs
 
Washington Examiner | Sally Pipes
October 16, 2022

Hospitals aren’t complying with a nearly 2-year-old federal rule requiring them to publish their prices, according to new research from PatientRightsAdvocate.org.

Their willingness to flout the law is understandable. They make more money when people don’t know how much the medical services they consume cost. But patients and payers shouldn’t stand for this intransigence. It’s depriving us of information we could use to foster competition among healthcare providers — and ultimately secure better care at a lower cost.


Read more. . .

Market-Based Principles Bring Us Quality Healthcare
 
Newsmax | Sally Pipes
October 17, 2022

A new poll from West Health and Gallup paints a grim picture of health care in the United States. Among the survey’s most striking findings is that three-quarters of the country grades the cost of care at either a D or an F.

Critics of our nation’s market-based health system are sure to see these survey findings as evidence that the status quo is broken. But what person wouldn’t want to pay less for health care — or any other good or service they desire?


Read more . . .